SARS-CoV-2 Screening Test for Japanese Returnees From Wuhan, China, January 2020

Author:

Kutsuna Satoshi1,Suzuki Tadaki2,Hayakawa Kayoko1,Tsuzuki Shinya3,Asai Yusuke3,Suzuki Tetsuya1,Ide Satoshi1,Nakamura Keiji1,Moriyama Yuki1,Kinoshita Noriko1,Hosokawa Naoto4,Osawa Ryosuke4,Yamamuro Ryosuke4,Akiyama Yutaro1,Miyazato Yusuke1,Nomoto Hidetoshi1,Nakamoto Takato1,Ota Masayuki1,Saito Sho1,Ishikane Masahiro1,Morioka Shinichiro1,Yamamoto Kei1,Ujiie Mugen1,Terada Mari1,Nakamura-Uchiyama Fukumi5,Sahara Toshinori5,Sano Masahiro6,Imamura Akifumi7,Sekiya Noritaka8,Fukushima Kazuaki7,Kawana Akihiko9,Fujikura Yuji9,Sano Tomoya9,Suematsu Ryohei9,Sakamoto Naoya10,Nagata Kaoru11,Kato Tomoyuki11,Katano Harutaka2,Wakita Takaji2,Sugiyama Haruhito12,Kokudo Norihiro12,Ohmagari Norio1ORCID

Affiliation:

1. Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan

2. COVID-19 NIID Evacuation Flight Laboratory Testing Team (NEFLATT), National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan

3. AMR Clinical Reference Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan

4. Department of Infectious Disease, Kameda Medical Center, Kamogawa City, Chiba, Japan

5. Department of Infectious Diseases, Ebara Hospital, Tokyo Metropolitan Health and Hospitals Corporation, Ota-ku, Tokyo, Japan

6. Department of Infectious Diseases, Toshima Hospital, Tokyo Metropolitan Health and Hospitals Corporation, Itabashi-ku, Tokyo, Japan

7. Department of Infectious Diseases, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo-ku, Tokyo, Japan

8. Department of Infection Prevention and Control, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo-ku, Tokyo, Japan

9. Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine, National Defense Medical College, Tokorozawa City, Saitama, Japan

10. Department of Infectious Diseases, Tokyo Metropolitan Bokutoh General Hospital, Sumida-ku, Tokyo, Japan

11. Japanese Red Cross Musashino Hospital, Musashino City, Tokyo, Japan

12. National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan

Abstract

Abstract Background Severe acute respiratory syndrome–related coronavirus 2 (SARS-CoV-2) was found to be the causative microorganism of coronavirus disease 2019 (COVID-19), which started to spread in Wuhan, China. This study was to evaluate the effectiveness of questionnaire, symptoms-based screening, and polymerase chain reaction (PCR) screening of returnees from COVID-19-endemic areas on a chartered flight, to examine the proportion of infected persons and the proportion of asymptomatic persons among infected persons who returned from Wuhan. Methods A retrospective cohort study was done in 7 tertiary medical institutions in Japan. A total of 566 Japanese who returned from Wuhan participated in the study. Results Overall, 11 of the 566 passengers had a positive SARS-CoV-2 PCR result for pharyngeal swabs and 6 were asymptomatic. Only fever differed between SARS-CoV-2-positive and -negative individuals (P < .043). Six of the 11 PCR-positive individuals were asymptomatic; 4 remained positive on day 10, and 1 asymptomatic person tested positive up to day 27. Two of the 11 were negative on the first PCR test and positive on the second. Conclusions Our results will be important insights on screening returnees from locked-down cities, as well as providing important data on the proportion of asymptomatic individuals infected with SARS-CoV-2. A 13-day observation period and a second round of PCR may be effective to screen patients, including asymptomatic infections.

Funder

National Center for Global Health and Medicine

Japan Agency for Medical Research and Development

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Reference24 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3